A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 588 participants.

Also called NCT04795531

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 588 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04795531
  • EudraCT 2020-000472-37
Other papers using this trial's data
  • Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes: The ONWARDS 3 Randomized Clinical Trial JAMA, 2023-07-18 DOI, PubMed 37354562, PMC10354685 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Austria, Brazil, Canada, China, Czechia, Denmark, France, Mexico, Puerto Rico, Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04795531. Randomized; quadruple masking; primary purpose treatment. Start 2021-03-24 (actual); primary completion 2022-06-23 (actual). Results posted on 2024-12-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)
Acronym
ONWARDS 3
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Insulin icodec
Intervention (Drug)
Placebo insulin icodec
Intervention (Drug)
Insulin degludec
Intervention (Drug)
Placebo insulin degludec
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct04795531
Content hash
8d920934e43dda8a4f7857de9ca6ebb643b1bccaf98c8b78d97f90aca27ce8ea